Archives

by in
Entry Author Date Location
Q&A With Bob Tepper on What’s Next for Third Rock Ventures 03/26/13 Boston
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More 05/10/12 San Diego
San Diego’s Celladon Extends Round to $53M, Opens European Office 05/08/12 San Diego
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
SD Life Sciences Roundup: Celladon, Gen-Probe, Organovo, and More 02/16/12 National
RetroSense Therapeutics Licenses Vision Restoration Technology From Wayne State 11/01/11 Detroit
Upping the Ante: San Diego Life Sciences Startups Raise More Cash 09/07/11 San Diego
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News 07/21/11 San Diego
Neurologix Forges Ahead on Gene Therapy Treatment for Parkinson’s 06/23/11 New York
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy 05/23/11 Boston
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting 05/23/11 San Francisco
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
Bluebird Bio Inks AFM Development Deal 03/16/11 Boston
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News 03/10/11 Seattle
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort 02/15/11 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Targeted Genetics Seeks Merger 11/12/10 Seattle
Ceregene Adds $11.5M 11/11/10 San Diego
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Xconomy Boston’s Top 20 Stories of the Third Quarter: From A123 Expansion to Zynga Acquisition 10/01/10 Boston
Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder 09/15/10 Boston
Seattle Children’s Moves in at Prominent Biotech Address as Targeted Genetics Moves Out 08/18/10 Seattle
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop 08/12/10 San Francisco
Gail Maderis, the Boston Biotech Exec Who Came Home to SF, Seeks to Give Back at BayBio 07/08/10 San Francisco
Ceregene Gets $2.5M From Fox Foundation 06/23/10 San Diego
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News 06/03/10 San Diego
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Automatic's App Puts Your Smartphone in Charge of Your Car

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.